OpenEvidence vs UpDoc

OpenEvidence offers a clean and responsive web application and native mobile apps with features like Quick Consult for rapid answers and Deep Consult for complex cases, along with widgets and shortcuts for fast access. User reviews consistently praise its speed, ease of use, and ability to provide well-organized, evidence-based answers. UpDoc's Australian platform also receives positive feedback for convenience and quick consultations, but some users report issues with billing clarity and customer support, which can impact overall usability.

OpenEvidence provides AI-powered natural language question answering grounded in peer-reviewed medical literature from reputable sources like NEJM, JAMA, NCCN, and Cochrane, with fully referenced answers. It also offers tools for clinical documentation and real-time decision support. UpDoc is FDA-cleared for physician-level care and continuous, evidence-based clinical interventions for chronic disease management, specifically for insulin management in adults with type 2 diabetes. While UpDoc's FDA clearance is a strong indicator of clinical value in its specific niche, OpenEvidence's broader application as a comprehensive, evidence-based clinical decision support and documentation tool, coupled with its extensive partnerships with leading medical journals, gives it an edge in overall clinical utility.

OpenEvidence is free for verified U.S. healthcare professionals, making it highly accessible and a strong value proposition for individual clinicians. Its revenue model relies on advertising and enterprise subscriptions for EHR integration. UpDoc offers various subscription models for unlimited consultations, with prices ranging from $19.95 to $99.95, and some users have reported issues with billing clarity. The free access for OpenEvidence provides superior value for individual practitioners, despite the presence of ads.

OpenEvidence is designed for EHR integration, with announced collaborations with major health systems like Mount Sinai and Cedars-Sinai for Epic integration. It is HIPAA compliant and offers enterprise pricing models for EHR integration and data insights. UpDoc is also EHR and workflow integrated, HIPAA, GDPR, and SOC 2 compliant, and targets enterprise health systems. However, OpenEvidence's established partnerships with multiple large health systems and its widespread adoption among US physicians (over 690,000 licensed-verified U.S. physicians as of July 2026) suggest a more advanced stage of enterprise readiness and proven scalability.

OpenEvidence demonstrates innovation through its AI-powered natural language question answering grounded in extensive peer-reviewed literature and its 'EvidenceGrade' feature, which grades and visualizes the quality of cited evidence. UpDoc showcases innovation with its FDA-cleared agentic AI platform that delivers physician-level care and continuous, evidence-based clinical interventions for chronic disease management between patient visits. Both tools present significant innovations in their respective areas of clinical AI, making it difficult to declare a definitive winner in this dimension.

Neither the provided structured facts nor web searches offer extensive details on the specifics of customer support or comprehensive documentation for either OpenEvidence or UpDoc. While both are enterprise-focused and likely provide adequate support, there is insufficient public information to distinguish between them in this dimension.